Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY) Short Interest Down 50.0% in May

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY) was the target of a large decrease in short interest during the month of May. As of May 29th, there was short interest totaling 39,619 shares, a decrease of 50.0% from the May 14th total of 79,267 shares. Based on an average daily trading volume, of 84,492 shares, the short-interest ratio is presently 0.5 days. Approximately 0.0% of the shares of the company are short sold.

Analysts Set New Price Targets

A number of brokerages have issued reports on OTSKY. The Goldman Sachs Group cut shares of Otsuka from a “strong-buy” rating to a “strong sell” rating in a report on Friday, February 27th. Zacks Research raised shares of Otsuka from a “strong sell” rating to a “hold” rating in a report on Tuesday, March 31st. One research analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold”.

Otsuka Trading Down 1.0%

Shares of OTSKY stock opened at $32.06 on Friday. Otsuka has a 1 year low of $21.68 and a 1 year high of $37.52. The firm has a market capitalization of $34.44 billion and a PE ratio of 13.53. The stock has a fifty day moving average of $34.68 and a two-hundred day moving average of $32.28. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.67 and a current ratio of 2.17.

Otsuka (OTCMKTS:OTSKY) last issued its quarterly earnings data on Tuesday, April 28th. The company reported $0.59 earnings per share for the quarter, beating analysts’ consensus estimates of $0.43 by $0.16. The business had revenue of $3.96 billion for the quarter, compared to analysts’ expectations of $3.78 billion. Otsuka had a net margin of 15.01% and a return on equity of 12.33%. Otsuka has set its FY 2026 guidance at 1.610-1.610 EPS. As a group, research analysts expect that Otsuka will post 1.98 EPS for the current year.

About Otsuka

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.